Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Menaka Pai"'
Autor:
Hasmik Nazaryan, Megan Watson, Dana Ellingham, Swarni Thakar, Andrea Wang, Menaka Pai, Yang Liu, Bram Rochwerg, Nadia Gabarin, Donald Arnold, Emily Sirotich, Michelle P. Zeller
Publikováno v:
Systematic Reviews, Vol 12, Iss 1, Pp 1-7 (2023)
Abstract Background Abnormal uterine bleeding (AUB), which includes heavy menstrual bleeding (HMB), is a common condition placing women at increased risk for developing iron deficiency and iron deficiency anemia (IDA). Depletion of iron stores has ne
Externí odkaz:
https://doaj.org/article/48fbd42ca8524b6a8a3fd328260c77dd
Autor:
Elizabeth Leung, Sumit Raybardhan, Christopher Graham, Caroline Nott, Bradley J Langford, Nisha Andany, William Ciccotelli, Sumon Chakrabarti, Isaac I Bogoch, Wayne L Gold, Menaka Pai, Andrew M Morris, Anne McCarthy
Publikováno v:
Canada Communicable Disease Report, Vol 47, Iss 78, Pp 316-321 (2021)
Ivermectin, an antiparasitic agent, is not recommended for prophylaxis or treatment of coronavirus disease 2019 (COVID-19). Inappropriate use of ivermectin for treatment of COVID-19 may make it less available for patients with serious parasitic infec
Externí odkaz:
https://doaj.org/article/1a57199d89684dd4971c0b64c4ca8dbb
Autor:
Elizabeth Leung, Sumit Raybardhan, Christopher Graham, Caroline Nott, Bradley J Langford, Nisha Andany, William Ciccotelli, Sumon Chakrabarti, Isaac I Bogoch, Wayne L Gold, Menaka Pai, Andrew M Morris, Anne McCarthy
Publikováno v:
Canada Communicable Disease Report, Vol 47, Iss 78, Pp 348-354 (2021)
L’ivermectine, un agent antiparasitaire, n’est pas recommandé pour la prophylaxie ou le traitement de la maladie à coronavirus 2019 (COVID-19). L’utilisation inappropriée de l’ivermectine pour le traitement de la COVID-19 peut en diminuer
Externí odkaz:
https://doaj.org/article/1910d72263da4a1f8704d594246f4c5f
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 6, Pp n/a-n/a (2021)
Abstract Adenoviral‐vector based vaccines for coronavirus disease 2019 (COVID‐19) have been linked with a thrombotic syndrome, vaccine‐induced thrombotic thrombocytopenia (VITT). A key clinical question is whether VITT can be reliably ruled out
Externí odkaz:
https://doaj.org/article/1dad7fdb5a754d7c9ef91c4b7a9df202
Autor:
Menaka Pai, Cindy H. T. Yeung, Elie A. Akl, Andrea Darzi, Christopher Hillis, Kimberly Legault, Joerg J. Meerpohl, Nancy Santesso, Domenica Taruscio, Madeleine Verhovsek, Holger J. Schünemann, Alfonso Iorio
Publikováno v:
BMC Medical Research Methodology, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Rare diseases are a global public health priority. Though each disease is rare, when taken together the thousands of known rare diseases cause significant morbidity and mortality, impact quality of life, and confer a social and ec
Externí odkaz:
https://doaj.org/article/46b709f2e0e44c94a12591b33c5f6c6f
Autor:
Menaka Pai, Neill K J Adhikari, Marlies Ostermann, Diane Heels-Ansdell, James D Douketis, Yoanna Skrobik, Ismael Qushmaq, Maureen Meade, Gordon Guyatt, William Geerts, Michael W Walsh, Mark A Crowther, Jan O Friedrich, Lisa Burry, Rinaldo Bellomo, Nilton Brandão da Silva, Rubens Costa Filho, Michael J Cox, Suzana Alves Silva, Deborah J Cook, PROTECT (Prophylaxis for Thromboembolism in Critical Care Trial) Investigators
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198285 (2018)
INTRODUCTION:There is concern about excessive bleeding when low-molecular-weight heparins (LMWHs) are used for venous thromboembolism (VTE) prophylaxis in renal dysfunction. Our objective was to evaluate whether LMWH VTE prophylaxis was safe and effe
Externí odkaz:
https://doaj.org/article/60ae9215aa484b53ada3833d6bc8e9fc
Autor:
Kanza Naveed, Nicola Goldberg, Eliane Shore, Arti Dhoot, Denise Gabrielson, Zahra Goodarzi, Yulia Lin, Menaka Pai, Natasha A. Pardy, Sue Robinson, Roseann Andreou, Manish Sood, Vicky Price, Sherri Storm, Ashley Verduyn, Michelle L. Parker, Michael Fralick, Daniel Beriault, Michelle Sholzberg
Publikováno v:
International Journal of Laboratory Hematology. 45:377-386
Iron deficiency is highly prevalent worldwide and is an issue of health inequity. Despite its high prevalence, uncertainty on the clinical applicability and evidence-base of iron-related lab test cut-offs remains. In particular, current ferritin deci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d27543080e611f356e265bd3c571f0af
https://doi.org/10.1111/ijlh.14016
https://doi.org/10.1111/ijlh.14016
Autor:
Michael Byrne, Ryan J Mattison, Rachel Sara Bercovitz, Richard Lottenberg, Suely Meireles Rezende, Roy L. Silverstein, Deirdra R Terrell, Robert Kunkle, Deion Smith, Catherine M. Bollard, Sandra L Haberichter, Jennifer Lin Holter-Chakrabarty, Menaka Pai, Matthew C Cheung, Adam Cuker, Matthew Seftel, Benjamin Djulbegovic
Publikováno v:
Blood Advances.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4d9b61835bdda9d8da4db8531451600
https://doi.org/10.1182/bloodadvances.2023010039
https://doi.org/10.1182/bloodadvances.2023010039
Autor:
Kanza Naveed, Nicola Goldberg, Eliane Shore, Arti Dhoot, Denise Gabrielson, Zahra Goodarzi, Yulia Lin, Menaka Pai, Natasha A. Pardy, Sue Robinson, Roseann Andreou, Manish Sood, Victoria Price, Ashley Verduyn, Michelle L. Parker, Michael Fralick, Daniel Beriault, Michelle Sholzberg
Publikováno v:
Blood. 140:11082-11084
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02c86ead1d263532794313b21cacbb0d
https://doi.org/10.1182/blood-2022-163741
https://doi.org/10.1182/blood-2022-163741
Autor:
Menaka Pai
Publikováno v:
Seminars in Hematology. 59:72-75
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a life-threatening syndrome of aggressive thrombosis, often profound thrombocytopenia, and frequently overt disseminated intravascular coagulation. It has been associated with 2 adenovirus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45753b0b6200de1e9b0869a063d004de
https://doi.org/10.1053/j.seminhematol.2022.02.002
https://doi.org/10.1053/j.seminhematol.2022.02.002